Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.39 |
| ▸ | CASP6 | P55212 | 1/20 | 0.39 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CFTR | P13569 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20345791 | 0.87 | KMT2A (0.43) | POLBALDH1A1NPSR1HTTKMT2A | |
| SCHEMBL22159501 | 0.84 | NPSR1 (0.42) | POLBALDH1A1NPSR1HTTKMT2A | |
| SCHEMBL4762963 | 0.83 | POLB (0.52) | POLBALDH1A1NPSR1HTTKMT2A | |
| SCHEMBL22831337 | 0.80 | NPSR1 (0.39) | POLBALDH1A1NPSR1HTTKMT2A | |
| SCHEMBL27989375 | 0.79 | KMT2A (0.50) | POLBALDH1A1NPSR1HTTKMT2A | |
| SCHEMBL14552277 | 0.78 | CA2 (0.38) | POLBALDH1A1NPSR1HTTKMT2A | |
| SCHEMBL23600021 | 0.77 | CA1 (0.32) | ALDH1A1NPSR1KMT2AMEN1CA2 | |
| SCHEMBL28530782 | 0.77 | KMT2A (0.44) | POLBALDH1A1NPSR1HTTKMT2A | |
| SCHEMBL14020795 | 0.76 | NPSR1 (0.52) | POLBALDH1A1NPSR1HTTKMT2A | |
| SCHEMBL134314 | 0.76 | POLB (0.47) | POLBALDH1A1NPSR1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111406059-B | Europium complexes | 东曹株式会社 | 2023-04-18 | — | — | CN | disclosed |
| US-20220064197-A1 | PHOSPHINE OXIDE GROUP-CONTAINED TRANSITION METAL COMPLEX, AND POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE THEREOF | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2022-03-03 | — | — | US | disclosed |
| US-10988494-B2 | Europium complex | TOSOH CORPORATION (JP) | 2021-04-27 | — | — | US | disclosed |
| US-20200354389-A1 | EUROPIUM COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2020-11-12 | — | — | US | disclosed |
| CN-111406059-A | Europium complexes | 东曹株式会社 | 2020-07-10 | — | — | CN | disclosed |
| WO-2020125589-A1 | PHOSPHINE OXIDE GROUP-CONTAINED TRANSITION METAL COMPLEX, AND POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE THEREOF | 广州华睿光电材料有限公司 | 2020-06-25 | — | — | WO | disclosed |
| EP-3281238-A1 | SEMICONDUCTING MATERIAL COMPRISING A PHOSPHINE OXIDE MATRIX AND METAL SALT | Novaled GmbH (DE) | 2018-02-14 | — | — | EP | disclosed |
| EP-2212339-B1 | BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS | SOLVIAS AG (CH) | 2018-01-10 | — | — | EP | disclosed |
| CN-107226827-A | A kind of preparation method of chiral phosphorus fluorenes oxide | 杭州师范大学 | 2017-10-03 | — | — | CN | disclosed |
| US-20170194576-A1 | Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2017-07-06 | — | — | US | disclosed |
| US-20170194576-A1 | Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2017-07-06 | — | — | US | disclosed |
| US-8598371-B2 | Bidentate chiral ligands for use in catalytic asymmetric addition reactions | SOLVIAS AG (CH) | 2013-12-03 | — | — | US | disclosed |
| US-20130267714-A1 | BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS | SOLVIAS AG (CH) | 2013-10-10 | — | — | US | disclosed |
| US-8450501-B2 | Bidentate chiral ligands for use in catalytic asymmetric addition reactions | SOLVIAS AG (CH) | 2013-05-28 | — | — | US | disclosed |
| US-20110118482-A1 | BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS | SOLVIAS AG | 2011-05-19 | — | — | US | disclosed |
| EP-2212339-A1 | BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS | Solvias AG (CH) | 2010-08-04 | — | — | EP | disclosed |
| WO-2009065784-A1 | BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS | SOLVIAS AG (CH) | 2009-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10988494-B2 | Europium complex | SSB, XPA, UACA | POLB 2679/4885ALDH1A1 3892/4885NPSR1 3070/4885 |
| US-20200354389-A1 | EUROPIUM COMPLEX | SSB, XPA, UACA | POLB 2679/4885ALDH1A1 3892/4885NPSR1 3070/4885 |
| US-20170194576-A1 | Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs | TRPM2, OCIAD2, TRPM6 | POLB 2756/4885ALDH1A1 1748/4885NPSR1 1540/4885 |
| US-20130267714-A1 | BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS | C1R, PNISR, CBR1 | POLB 279/4885ALDH1A1 2792/4885NPSR1 219/4885 |
| US-20220064197-A1 | PHOSPHINE OXIDE GROUP-CONTAINED TRANSITION METAL COMPLEX, AND POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE THEREOF | PHOSPHO1, CPNE4, TCP1 | POLB 723/4885ALDH1A1 4298/4885NPSR1 3747/4885 |
| US-20110118482-A1 | BIDENTATE CHIRAL LIGANDS FOR USE IN CATALYTIC ASYMMETRIC ADDITION REACTIONS | H1-2, H1-0, C1R | POLB 112/4885ALDH1A1 3555/4885NPSR1 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.